Literature DB >> 16025957

[Clinical study on treatment of non-alcoholic fatty liver of damp-heat syndrome type by danning tablet].

Guang Ji1, Jian-gao Fan, Jian-jie Chen.   

Abstract

OBJECTIVE: To evaluate the therapeutic effect of Danning Tablet (DNT) on patients with non-alcoholic fatty liver (NAFL) of damp-heat Syndrome type.
METHODS: Multi-center randomized double-blinded positive medicine parallel controlled method was adopted. One hundred and two patients were treated with DNT and 33 patients treated with Ursodeoxycholic acid (UDCA) as control. Indexes including body mass index (MBI), principal symptom, liver function, blood lipids, iconographic parameters and comprehensive efficacy were measured before and after treatment in the two groups respectively.
RESULTS: DNT and UDCA had the effect in improving BMI, distress in hepatic region, fatigue, anorexia, liver function, blood lipids and iconographic parameters, etc. DNT showed effects in improving BMI and distress in hepatic region better than those of UDCA. Histological examination also showed that DNT had good therapeutic effect.
CONCLUSION: DNT is an effective medicine for NAFL patients of damp-heat Syndrome type, and its efficacy is better than that of UDCA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025957

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  3 in total

1.  Effect of tiaozhi yanggan decoction in treating patients with non-alcoholic fatty liver.

Authors:  Can-li Gu; Yun-ke Zhang; Yue-xiao Fu; Shao-feng Yang; Xin-qiang Li
Journal:  Chin J Integr Med       Date:  2007-12       Impact factor: 1.978

Review 2.  Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Ke-Qing Shi; Yu-Chen Fan; Wen-Yue Liu; Ling-Fei Li; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

Review 3.  Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets.

Authors:  Jie Liu; Yun Shi; Daiyin Peng; Lei Wang; Nianjun Yu; Guokai Wang; Weidong Chen
Journal:  Front Cardiovasc Med       Date:  2022-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.